Rein Therapeutics, Inc. Operating Cash Flow
Rein Therapeutics, Inc. (RNTX) reported Operating Cash Flow of -$12.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Rein Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$8.64M.
- Rein Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.42M.
- Rein Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.22M.
- Rein Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.55M.
- Rein Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$19.36M.
- Rein Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$22.29M.
- Rein Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$19.81M.
- Rein Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$24.86M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$12.06M 10-Q · filed 2026-08-14 | -$15.28M derived: sum of 3 quarters · filed 2026-08-14 | -$18.83M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$3.42M 10-Q · filed 2026-05-15 | -$6.64M derived: sum of 2 quarters · filed 2026-05-15 | -$10.19M derived: sum of 3 quarters · filed 2026-05-15 | -$16.61M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$6.77M derived: sum of 2 quarters · filed 2026-03-26 | -$13.19M derived: sum of 3 quarters · filed 2026-08-14 | -$19.36M 10-K · filed 2026-03-26 |
| 2025-09-30 | -$3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$9.97M derived: sum of 2 quarters · filed 2026-08-14 | -$16.14M 10-Q · filed 2025-11-14 | -$20.95M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$6.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$12.59M 10-Q · filed 2026-08-14 | -$17.41M derived: sum of 3 quarters · filed 2026-08-14 | -$21.22M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$6.17M 10-Q · filed 2026-05-15 | -$10.99M derived: sum of 2 quarters · filed 2026-05-15 | -$14.81M derived: sum of 3 quarters · filed 2026-05-15 | -$23.20M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$8.63M derived: sum of 2 quarters · filed 2026-03-26 | -$17.02M derived: sum of 3 quarters · filed 2026-03-26 | -$22.29M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$12.21M derived: sum of 2 quarters · filed 2025-11-14 | -$17.48M 10-Q · filed 2025-11-14 | -$27.87M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$8.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$13.66M 10-Q · filed 2025-08-14 | -$24.05M derived: sum of 3 quarters · filed 2025-08-14 | -$25.69M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$5.27M 10-Q · filed 2025-05-15 | -$15.66M derived: sum of 2 quarters · filed 2025-05-15 | -$17.30M derived: sum of 3 quarters · filed 2025-05-15 | -$20.42M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$10.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | -$12.03M derived: sum of 2 quarters · filed 2025-04-07 | -$15.15M derived: sum of 3 quarters · filed 2025-04-07 | -$19.81M 10-K · filed 2025-04-07 |
| 2023-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$4.76M derived: sum of 2 quarters · filed 2024-11-14 | -$9.42M 10-Q · filed 2024-11-14 | -$13.83M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$7.78M 10-Q · filed 2024-08-14 | -$12.19M derived: sum of 3 quarters · filed 2024-08-14 | -$19.16M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$4.66M 10-Q · filed 2024-05-15 | -$9.07M derived: sum of 2 quarters · filed 2024-05-15 | -$16.04M derived: sum of 3 quarters · filed 2024-05-15 | -$21.73M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | -$11.38M derived: sum of 2 quarters · filed 2024-04-15 | -$17.07M derived: sum of 3 quarters · filed 2024-04-15 | -$24.86M 10-K · filed 2024-04-15 |
| 2022-09-30 | -$6.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-13 | -$12.66M derived: sum of 2 quarters · filed 2023-10-13 | -$20.46M 10-Q · filed 2023-10-13 | -$26.71M derived: sum of 4 quarters · filed 2023-10-13 |
| 2022-06-30 | -$5.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$13.48M 10-Q · filed 2023-08-11 | -$19.74M derived: sum of 3 quarters · filed 2023-08-11 | -$27.00M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$7.80M 10-Q · filed 2023-05-08 | -$14.05M derived: sum of 2 quarters · filed 2023-05-08 | -$21.32M derived: sum of 3 quarters · filed 2023-05-08 | -$25.08M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$13.52M derived: sum of 2 quarters · filed 2023-03-20 | -$17.28M derived: sum of 3 quarters · filed 2023-03-20 | -$23.75M 10-K · filed 2023-03-20 |
| 2021-09-30 | -$7.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$11.02M derived: sum of 2 quarters · filed 2022-11-01 | -$17.50M 10-Q · filed 2022-11-01 | -$22.19M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | -$3.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$10.24M 10-Q · filed 2022-08-15 | -$14.93M derived: sum of 3 quarters · filed 2022-08-15 | -$19.97M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$6.48M 10-Q · filed 2022-05-05 | -$11.16M derived: sum of 2 quarters · filed 2022-05-05 | -$16.21M derived: sum of 3 quarters · filed 2022-05-05 | -$21.28M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$9.73M derived: sum of 2 quarters · filed 2022-03-28 | -$14.80M derived: sum of 3 quarters · filed 2022-03-28 | -$20.48M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$5.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$10.12M derived: sum of 2 quarters · filed 2021-11-12 | -$15.79M 10-Q · filed 2021-11-12 | -$22.09M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$10.74M 10-Q · filed 2021-08-11 | -$17.05M derived: sum of 3 quarters · filed 2021-08-11 | -$24.02M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$5.67M 10-Q · filed 2021-05-11 | -$11.98M derived: sum of 2 quarters · filed 2021-05-11 | -$18.95M derived: sum of 3 quarters · filed 2021-05-11 | -$24.64M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$13.28M derived: sum of 2 quarters · filed 2021-03-24 | -$18.97M derived: sum of 3 quarters · filed 2021-03-24 | -$26.47M 10-K · filed 2021-03-24 |
| 2019-09-30 | -$6.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$12.67M derived: sum of 2 quarters · filed 2020-11-12 | -$20.17M 10-Q · filed 2020-11-12 | -$26.83M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$5.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$13.19M 10-Q · filed 2020-08-05 | -$19.86M derived: sum of 3 quarters · filed 2020-08-05 | -$26.73M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$7.50M 10-Q · filed 2020-05-11 | -$14.16M derived: sum of 2 quarters · filed 2020-05-11 | -$21.04M derived: sum of 3 quarters · filed 2020-05-11 | -$28.50M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$13.54M derived: sum of 2 quarters · filed 2020-03-30 | -$21.00M derived: sum of 3 quarters · filed 2020-03-30 | -$27.93M 10-K · filed 2020-03-30 |
| 2018-09-30 | -$6.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$14.33M derived: sum of 2 quarters · filed 2019-11-07 | -$21.26M 10-Q · filed 2019-11-07 | -$27.10M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$7.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$14.38M 10-Q · filed 2019-08-06 | -$20.22M derived: sum of 3 quarters · filed 2019-08-06 | -$25.46M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$6.93M 10-Q · filed 2019-05-08 | -$12.77M derived: sum of 2 quarters · filed 2019-05-08 | -$18.00M derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$11.07M derived: sum of 2 quarters · filed 2019-03-29 | -$20.53M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$14.69M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$9.46M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |